Politicians from across the political spectrum are up in arms over healthcare giant Sanofi’s plans to sell France’s best-known medical drug Doliprane to US investors, a move critics say would lead to a “loss of sovereignty” for the country in a sensitive industry.
Related Posts
Paris Olympics opening ceremony dancers call off strike after reaching pay deal, union says
Hundreds of dancers set to perform Friday at the Paris Olympics opening ceremony have called off a planned strike over pay disparities after reaching a […]
Teddy Riner defends France’s Olympic title in mixed team judo against Japan
French star Teddy Riner Saturday helped his country defend its Olympic title in mixed team judo, after he beat Japan’s Tatsuru Saito in the final for the second […]
An operatic experience like no other: ‘The Opera Locos’ returns to Paris
Exposing children to opera is not always easy. Traditional productions can last three hours or more, but a French show called “The Opera Locos” is […]